Citigroup
CAMP icon

Citigroup’s CAMP4 Therapeutics CAMP Stock Holding History

Citigroup’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$43.6K Sell
9,887
-11,516
-54% -$54.7K ﹤0.01% 4574
2025
Q4 		$131K Buy
+21,403
New +$91K ﹤0.01% 4195
2025
Q2 		– Sell
-5,008
Closed -$20K – 5669
2025
Q1 		$20K Sell
5,008
-432
-8% -$2.09K ﹤0.01% 5092
2024
Q4 		$28.4K Buy
+5,440
New +$44.7K ﹤0.01% 5217

Other funds holding CAMP

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $352M AUM 220.14% 1-Year Est. Return
ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $437M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Citigroup's CAMP Position: Q1 2026 in Review

Citigroup reduced its CAMP4 Therapeutics (CAMP) stake by 54% in Q1 2026, selling an estimated $54.7K and leaving 9,887 shares worth $43.6K. The position accounts for ﹤0.01% of the portfolio, ranked #4574.

Citigroup first reported a position in CAMP in Q4 2024 and has held it in 4 quarters since. The position peaked at $131K in Q4 2025. 46 funds tracked by Wall St. Rank hold CAMP as of Q1 2026.

  • Citigroup held 9,887 shares of CAMP4 Therapeutics worth $43.6K as of Q1 2026.
  • Citigroup sold 11,516 CAMP4 Therapeutics shares in Q1 2026, an estimated $54.7K.
  • CAMP4 Therapeutics made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #4574 holding.
  • Citigroup first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 4 quarters since.
  • Citigroup's CAMP4 Therapeutics position peaked at $131K in Q4 2025.
  • 46 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.